🔬 This Week’s Top Biotech News Here are the biggest stories shaping the world of biotechnology this week 👇 Eisai – Health Canada Grants Authorization for LEQEMBI® (lecanemab) for Early Alzheimer’s DiseaseBiopharma Embraces Synthetic BiologySanofi-Aventis Canada – Dupixent® (dupilumab injection) approved for COPDStockWatch: Intellia Shares Sink as Clinical Hold Follows Safety SetbackBird Flu’s Human Risk Spurs Phage Therapy ResearchThis Retina Implant Lets People with Vision Loss Do a Crosswor...
All content for BioTech Weekly is the property of Ernst Oberortner and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
🔬 This Week’s Top Biotech News Here are the biggest stories shaping the world of biotechnology this week 👇 Eisai – Health Canada Grants Authorization for LEQEMBI® (lecanemab) for Early Alzheimer’s DiseaseBiopharma Embraces Synthetic BiologySanofi-Aventis Canada – Dupixent® (dupilumab injection) approved for COPDStockWatch: Intellia Shares Sink as Clinical Hold Follows Safety SetbackBird Flu’s Human Risk Spurs Phage Therapy ResearchThis Retina Implant Lets People with Vision Loss Do a Crosswor...
🚀 Biotech & Life Sciences Weekly Highlights 🌱 Privacy Under Fire: 27 states and D.C. are suing 23andMe to stop the sale of personal genetic data without consent — as Regeneron eyes acquisition during bankruptcy proceedings.Organoid Innovation: Pluristyx launches the PluriForm™ Organoid Kit, dramatically cutting down organoid development timelines with ready-to-differentiate iPSCs.Funding Milestone: Genesys Capital closes its largest fund yet — Genesys Ventures IV LP — backing Canadian lif...
BioTech Weekly
🔬 This Week’s Top Biotech News Here are the biggest stories shaping the world of biotechnology this week 👇 Eisai – Health Canada Grants Authorization for LEQEMBI® (lecanemab) for Early Alzheimer’s DiseaseBiopharma Embraces Synthetic BiologySanofi-Aventis Canada – Dupixent® (dupilumab injection) approved for COPDStockWatch: Intellia Shares Sink as Clinical Hold Follows Safety SetbackBird Flu’s Human Risk Spurs Phage Therapy ResearchThis Retina Implant Lets People with Vision Loss Do a Crosswor...
